Evaluation of miR-let-7f, miR-125a, and miR-125b expression levels in sputum and serum samples of Iranians and Afghans with pulmonary tuberculosis

被引:1
作者
Neamatollahi, Ali Nour [1 ]
Tarashi, Samira [1 ]
Ebrahimzadeh, Nayereh [1 ]
Vaziri, Farzam [1 ,2 ]
Birgani, Mohammad Ali Zaheri [3 ]
Aghasadeghi, Mohammadreza [3 ,4 ]
Fateh, Abolfazl [1 ,2 ]
Siadat, Seyed Davar [1 ,2 ]
Bouzari, Saeid [5 ]
机构
[1] Pasteur Inst Iran, Dept Mycobacteriol & Pulm Res, Tehran, Iran
[2] Pasteur Inst Iran, Microbiol Res Ctr MRC, Tehran, Iran
[3] Pasteur Inst Iran, Dept Hepatitis & AIDS, Tehran, Iran
[4] Pasteur Inst Iran, Viral Vaccine Res Ctr, Tehran, Iran
[5] Pasteur Inst Iran, Dept Mol Biol, Tehran, Iran
关键词
Mycobacterium tuberculosis; MicroRNA; Sputum; Serum; MYCOBACTERIUM-TUBERCULOSIS; IDENTIFICATION; INFECTION; AUTOPHAGY; MICRORNAS;
D O I
暂无
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background and Objectives: The role of microRNAs (miRNAs) in tuberculosis infection is well established. As microRNAs are able to change expression profiles according to different conditions, they can be useful biomarkers. Iranians and Afghans with tuberculosis were studied for three immune-related miRNAs (miR-let-7f, miR-125a, and miR-125b).Materials and Methods: A total of 60 Iranian and Afghan patients with active pulmonary TB were enrolled in the Pulmonary Department of the Pasteur Institute of Iran. Serum and sputum samples were collected simultaneously from all participants. A Real-time PCR was conducted to detect differentially expressed miRNAs.Results: Iranian (P<0.0001) and Afghan (P<0.0001) serum samples and Afghan (P<0.0001) sputum samples overexpressed miR-125a, whereas Iranian sputum samples showed downregulation (P=0.0039). In both Iranian (P<0.0001; P=0.0007) and Afghan (P<0.0001; P<0.0001) serum and sputum samples, miR-125b was overexpressed. Furthermore, miR-let-7f down regulation was observed in serum and sputum samples (P<0.0001), whereas Iranian sputum samples had no statistically significant differences (P=0.348).Conclusion: Overexpression of miR-125a and miR-125b has been detected in Iranian and Afghan samples. In both races, miR-let-7f downregulation has been confirmed. Identification of miRNA profiles under different conditions opens the door to evaluating potential new biomarkers for diagnosis, disease monitoring, and therapeutic markers in TB infection.
引用
收藏
页码:665 / 673
页数:9
相关论文
共 50 条
  • [21] Prognostic Significance of Serum miR-22, miR-125b, and miR-15b in Non-Small Cell Lung Cancer Patients
    Shi, Guang-Li
    Zhang, Xin-Yong
    Chen, Yan
    Ma, Shang
    Bai, Wan-Qiu
    Yin, Yan-Jun
    CLINICAL LABORATORY, 2020, 66 (06) : 1105 - 1112
  • [22] The microRNA molecular signature of atypic and common acquired melanocytic nevi: differential expression of miR-125b and let-7c
    Holst, Line Marie Brokso
    Kaczkowski, Bogumil
    Glud, Martin
    Futoma-Kazmierczak, Ewa
    Hansen, Lennart Friis
    Gniadecki, Robert
    EXPERIMENTAL DERMATOLOGY, 2011, 20 (03) : 278 - 280
  • [23] TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression
    Ottaviani, Silvia
    Stebbing, Justin
    Frampton, Adam E.
    Zagorac, Sladjana
    Krell, Jonathan
    de Giorgio, Alexander
    Trabulo, Sara M.
    Nguyen, Van T. M.
    Magnani, Luca
    Feng, Hugang
    Giovannetti, Elisa
    Funel, Niccola
    Gress, Thomas M.
    Jiao, Long R.
    Lombardo, Ylenia
    Lemoine, Nicholas R.
    Heeschen, Christopher
    Castellano, Leandro
    NATURE COMMUNICATIONS, 2018, 9
  • [24] Differential expression of microRNAs miR-21, miR-31, miR-203, miR-125a-5p and miR-125b and proteins PTEN and p63 in verrucous carcinoma of the head and neck
    Odar, Katarina
    Bostjancic, Emanuela
    Gale, Nina
    Glavac, Damjan
    Zidar, Nina
    HISTOPATHOLOGY, 2012, 61 (02) : 257 - 265
  • [25] MiR-21, miR-34a, miR-125b, miR-181d and miR-648 levels inversely correlate with MGMT and TP53 expression in primary glioblastoma patients
    Jesionek-Kupnicka, Dorota
    Braun, Marcin
    Trabska-Kluch, Berenika
    Czech, Joanna
    Szybka, Malgorzata
    Szymanska, Bozena
    Kulczycka-Wojdala, Dominika
    Bienkowski, Michal
    Kordek, Radzislaw
    Zawlik, Izabela
    ARCHIVES OF MEDICAL SCIENCE, 2019, 15 (02) : 504 - 512
  • [26] Hsa-miR-99b/let-7e/miR-125a Cluster Regulates Pathogen Recognition Receptor-Stimulated Suppressive Antigen-Presenting Cells
    Hildebrand, Dagmar
    Eberle, Mariel-Esther
    Woelfle, Sabine Marie
    Egler, Franziska
    Sahin, Delal
    Saehr, Aline
    Bode, Konrad A.
    Heeg, Klaus
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [27] Estradiol Suppresses NF-κB Activation through Coordinated Regulation of let-7a and miR-125b in Primary Human Macrophages
    Murphy, Amy J.
    Guyre, Paul M.
    Pioli, Patricia A.
    JOURNAL OF IMMUNOLOGY, 2010, 184 (09) : 5029 - 5037
  • [28] Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b
    Kim, Jeong Kyu
    Noh, Ji Heon
    Jung, Kwang Hwa
    Eun, Jung Woo
    Bae, Hyun Jin
    Kim, Min Gyu
    Chang, Young Gyoon
    Shen, Qingyu
    Park, Won Sang
    Lee, Jung Young
    Borlak, Juergen
    Nam, Suk Woo
    HEPATOLOGY, 2013, 57 (03) : 1055 - 1067
  • [29] miR-125b expression affects tumor growth of multiple myeloma via targeting MKK7
    Jiang, Yanxia
    Luan, Yajing
    He, Dong
    Chen, Guoan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (08): : 8487 - 8494
  • [30] Downregulation of miR-99a/let-7c/miR-125b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma
    Truini, Anna
    Coco, Simona
    Nadal, Ernest
    Genova, Carlo
    Mora, Marco
    Dal Bello, Maria Giovanna
    Vanni, Irene
    Alama, Angela
    Rijavec, Erika
    Biello, Federica
    Barletta, Giulia
    Merlo, Domenico Franco
    Valentino, Alessandro
    Ferro, Paola
    Ravetti, Gian Luigi
    Stigliani, Sara
    Vigani, Antonella
    Fedeli, Franco
    Beer, David G.
    Roncella, Silvio
    Grossi, Francesco
    ONCOTARGET, 2017, 8 (40) : 68627 - 68640